title: Efficacy and complications of polyethylene glycols for treatment of constipation in children: a meta-analysis.
abstract: Constipation is a common childhood complaint. In 90% to 95% of children, constipation is functional, which means that there is no objective evidence of an underlying pathological condition. Polyethylene glycol (PEG or macrogol) solution is an osmotic laxative agent that is absorbed in only trace amounts from the gastrointestinal tract and routinely used to treat chronic constipation in adults. Here, we report the results of a meta-analysis of PEG-based laxatives compared with lactulose, milk of magnesia (magnesium hydroxide), oral liquid paraffin (mineral oil), or acacia fiber, psyllium fiber, and fructose in children. This meta-analysis was conducted in accordance with PRISMA guidelines and involved searches of MEDLINE, Cochrane, EMBASE, and Google Scholar databases up to February 10, 2014, using the keywords (Constipation OR Functional Constipation OR Fecal Impaction) AND (Children) AND (Polyethylene Glycol OR Laxative). Primary efficacy outcomes included a number of stool passages/wk and percentage of patients who reported satisfactory stool consistency. Secondary safety outcomes included diarrhea, abdominal pain, nausea or vomiting, pain or straining at defecation, bloating or flatulence, hard stool consistency, poor palatability, and rectal bleeding. We identified 231 articles, 27 of which were suitable for full-text review and 10 of which were used in the meta-analysis. Patients who were treated with PEG experienced more successful disimpaction compared with those treated with non-PEG laxatives. Treatment-related adverse events were acceptable and generally well tolerated. PEG-based laxatives are effective and safe for chronic constipation and for resolving fecal impaction in children. Children's acceptance of PEG-based laxatives appears to be better than non-PEG laxatives. Optimal dosages, routes of administration, and PEG regimens should be determined in future randomized controlled studies and meta-analyses.
authors.affiliation: Department of Gastrointestinal and Pancreatic Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou (S-LC, S-RC, LD, X-HZ, J-JP, J-BX, W-FL, C-QC, J-PM, Y-LH); and Department of Gastrointestinal Surgery, the First People's Hospital of Foshan, Foshan (T-DL), Guangdong Province, China.
authors.forename: Si-Le
authors.initials: SL
authors.lastname: Chen
authors.forename: Shi-Rong
authors.initials: SR
authors.lastname: Cai
authors.forename: Liang
authors.initials: L
authors.lastname: Deng
authors.forename: Xin-Hua
authors.initials: XH
authors.lastname: Zhang
authors.forename: Te-Dong
authors.initials: TD
authors.lastname: Luo
authors.forename: Jian-Jun
authors.initials: JJ
authors.lastname: Peng
authors.forename: Jian-Bo
authors.initials: JB
authors.lastname: Xu
authors.forename: Wen-Feng
authors.initials: WF
authors.lastname: Li
authors.forename: Chuang-Qi
authors.initials: CQ
authors.lastname: Chen
authors.forename: Jin-Ping
authors.initials: JP
authors.lastname: Ma
authors.forename: Yu-Long
authors.initials: YL
authors.lastname: He
mesh_terms: D002648:Child; D002908:Chronic Disease; D003248:Constipation / Q000188:drug therapy*; D006801:Humans; D054368:Laxatives / Q000627:therapeutic use*; D015233:Models, Statistical; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D054368:Laxatives; D011092:Polyethylene Glycols